WASHINGTON, Oct 24 (Reuters) - A warning is being added to
Cephalon Inc's (CEPH.O: Quote, Profile, Research) drug Provigil for excessive sleepiness
because of the risk of serious skin rash and psychiatric
symptoms, the U.S. Food and Drug Administration said on
Wednesday.
